查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599202

血管損傷治療市場：按損傷、治療、最終用戶分類 - 2025-2030 年全球預測

Vascular Injury Treatment Market by Injury (Aneurysm & Pseudoaneurysm, Arteriovenous Fistula, Contusion or Intimal Flap), Treatment (Bypass Graft, Extra Anatomic Bypass, Lateral Arteriorrhaphy or Venorrhaphy), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，血管損傷治療市場估值為215.1億美元，預計2024年將達到244.5億美元，複合年成長率為13.76%，到2030年將達到530.4億美元。

血管損傷治療包括各種醫療干預措施，旨在管理和修復因創傷、手術併發症或某些醫療狀況而可能發生的血管損傷。這種必要性是由於血管在循環系統中發揮重要作用，支持組織活力和整體身體功能。應用包括緊急創傷治療、血管手術和重組手術。最終使用區域主要是醫院、創傷中心和專業外科病房。

主要市場統計
基準年[2023] 215.1億美元
預測年份 [2024] 244.5億美元
預測年份 [2030] 530.4億美元
複合年成長率（%） 13.76%

血管損傷治療市場的成長受到創傷發生率增加、動脈瘤和血栓症等血管疾病盛行率上升以及醫療技術進步等因素的影響。此外，世界人口老化進一步增加了需求，因為老年人更容易出現血管併發症。血管內手術等微創手術的普及代表了一個重大商機，因為它縮短了恢復時間並降低了手術風險。公司可以透過投資開發尖端設備並擴大與醫療保健提供者的夥伴關係關係來利用這些進步。

然而，市場面臨著限制和挑戰，包括先進血管手術和設備的高成本、監管障礙以及需要熟練人員進行複雜的干涉措施。此外，獲得醫療保健的地區差異也可能影響市場成長。

創新機會在於增強成像技術以實現更好的診斷和治療計劃的精確性、開發生物分解性的支架以及探索用於血管再生的幹細胞療法。材料科學的研究也可能有助於創造更耐用和生物相容性的血管移植物。市場競爭激烈，主要企業在研發方面投入巨資，以求脫穎而出。公司應專注於促進跨學科合作和改善醫療基礎設施，以簡化血管損傷治療並促進更廣泛的市場滲透。

市場動態：揭示快速發展的血管損傷治療市場的關鍵市場洞察

供需的動態交互作用正在改變血管損傷治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 血管損傷手術增加
    • 由於交通事故、割傷和暴力的增加，創傷發生率增加
    • 加強醫院合作，提供心臟相關疾病的治療解決方案
  • 市場限制因素
    • 血管損傷治療相關的高成本
  • 市場機會
    • 新興國家醫療旅遊的增加
    • 技術進步
  • 市場挑戰
    • 與血管損傷治療相關的副作用

波特五力：駕馭血管損傷治療市場的策略工具

波特的五力架構是了解血管損傷治療市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解血管損傷治療市場的外部影響

外部宏觀環境因素在塑造血管損傷治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解血管損傷治療市場的競爭狀況

對血管損傷治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣血管損傷治療市場供應商績效評估

FPNV 定位矩陣是評估血管損傷治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃血管損傷治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對血管損傷治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 血管損傷手術發生率增加
      • 由於道路事故、割傷和暴力的增加，創傷發生率增加
      • 加強醫院之間的合作，提供心臟相關疾病的治療解決方案
    • 抑制因素
      • 血管損傷治療相關的高成本
    • 機會
      • 醫療旅遊在新興國家的擴張
      • 加速科技進步
    • 任務
      • 與血管損傷治療相關的副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 損傷引起的血管損傷治療市場

  • 動脈瘤和假性動脈瘤
  • 動靜脈瘻管
  • 挫傷或內膜瓣
  • 撕裂或截肢
  • 抽搐
  • 血栓症

第7章依治療方式分類的血管損傷治療市場

  • 旁路移植術
  • 解剖搭橋術
  • 外側動脈或靜脈縫合
  • 補片血管成形術
  • 血栓切除術

第8章血管損傷治療市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第9章北美及南美血管損傷治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太血管損傷治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲血管損傷治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Abbott Laboratories
  • Aplagon Oy
  • Becton, Dickinson, and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cardiva Medical, Inc.
  • Cordis Corporation
  • Humacyte, Inc.
  • Medtronic PLC
  • Mentice AB
  • Teleflex Incorporated
  • Terumo Corporation
  • Vasorum Ltd.
  • Veryan Medical Ltd
  • Vivasure Medical Ltd.
Product Code: MRR-034B5003037C

The Vascular Injury Treatment Market was valued at USD 21.51 billion in 2023, expected to reach USD 24.45 billion in 2024, and is projected to grow at a CAGR of 13.76%, to USD 53.04 billion by 2030.

Vascular injury treatment encompasses a range of medical interventions designed to manage and repair damage to blood vessels, which can occur due to trauma, surgical complications, or certain medical conditions. Its necessity is driven by the critical role that blood vessels play in the circulatory system, supporting tissue viability and overall bodily function. Applications include emergency trauma care, vascular surgical procedures, and reconstructive techniques. End-use sectors primarily involve hospitals, trauma centers, and specialized surgical units.

KEY MARKET STATISTICS
Base Year [2023] USD 21.51 billion
Estimated Year [2024] USD 24.45 billion
Forecast Year [2030] USD 53.04 billion
CAGR (%) 13.76%

Market growth for vascular injury treatment is influenced by factors such as the increasing incidence of traumatic injuries, rising prevalence of vascular diseases like aneurysms and thrombosis, and advancements in medical technology. Additionally, an aging global population further intensifies demand, as older individuals are more susceptible to vascular complications. The surge in minimally invasive techniques, such as endovascular surgery, represents a significant opportunity, offering faster recovery times and reduced surgical risks. Companies can capitalize on these advancements by investing in developing cutting-edge devices and expanding partnerships with healthcare providers.

However, the market faces limitations and challenges, including the high cost of advanced vascular procedures and devices, regulatory hurdles, and the need for skilled practitioners to perform complex interventions. Furthermore, disparities in healthcare accessibility across different regions can affect market growth.

Innovation opportunities lie in enhancing imaging technologies for better diagnosis and precision in treatment plans, developing biodegradable stents, and exploring stem cell therapy for vascular regeneration. Research into materials science can also contribute to the creation of more durable and biocompatible vascular grafts. The market is characterized by robust competition, with key players investing heavily in research and development to differentiate their offerings. Businesses should focus on fostering interdisciplinary collaboration and improving healthcare infrastructure to streamline vascular injury treatment and facilitate wide-ranging market penetration.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Injury Treatment Market

The Vascular Injury Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of vascular injury surgeries
    • Rise in the occurrence of trauma due to the increase in the road accidents, cuts, violence
    • Increasing number of collaborations by hospital to provide therapeutic solution for heart related diseases
  • Market Restraints
    • High cost associated with the vascular injury treatment
  • Market Opportunities
    • Growing medical tourism in developing countries
    • Increasing advancement in technologies
  • Market Challenges
    • Side effects associated with vascular injury treatment

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Injury Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Injury Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Injury Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Injury Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Injury Treatment Market

A detailed market share analysis in the Vascular Injury Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Injury Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Injury Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Injury Treatment Market

A strategic analysis of the Vascular Injury Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Injury Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Aplagon Oy, Becton, Dickinson, and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cardiva Medical, Inc., Cordis Corporation, Humacyte, Inc., Medtronic PLC, Mentice AB, Teleflex Incorporated, Terumo Corporation, Vasorum Ltd., Veryan Medical Ltd, and Vivasure Medical Ltd..

Market Segmentation & Coverage

This research report categorizes the Vascular Injury Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Injury, market is studied across Aneurysm & Pseudoaneurysm, Arteriovenous Fistula, Contusion or Intimal Flap, Laceration or Transection, Spasm, and Thrombosis.
  • Based on Treatment, market is studied across Bypass Graft, Extra Anatomic Bypass, Lateral Arteriorrhaphy or Venorrhaphy, Patch Angioplasty, and Thrombectomy.
  • Based on End-User, market is studied across Ambulatory Surgical Center and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of vascular injury surgeries
      • 5.1.1.2. Rise in the occurrence of trauma due to the increase in the road accidents, cuts, violence
      • 5.1.1.3. Increasing number of collaborations by hospital to provide therapeutic solution for heart related diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the vascular injury treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing medical tourism in developing countries
      • 5.1.3.2. Increasing advancement in technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects associated with vascular injury treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Injury Treatment Market, by Injury

  • 6.1. Introduction
  • 6.2. Aneurysm & Pseudoaneurysm
  • 6.3. Arteriovenous Fistula
  • 6.4. Contusion or Intimal Flap
  • 6.5. Laceration or Transection
  • 6.6. Spasm
  • 6.7. Thrombosis

7. Vascular Injury Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Bypass Graft
  • 7.3. Extra Anatomic Bypass
  • 7.4. Lateral Arteriorrhaphy or Venorrhaphy
  • 7.5. Patch Angioplasty
  • 7.6. Thrombectomy

8. Vascular Injury Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Center
  • 8.3. Hospital

9. Americas Vascular Injury Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Vascular Injury Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Vascular Injury Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. Aplagon Oy
  • 4. Becton, Dickinson, and Company
  • 5. Boston Scientific Corporation
  • 6. Cardinal Health, Inc.
  • 7. Cardiva Medical, Inc.
  • 8. Cordis Corporation
  • 9. Humacyte, Inc.
  • 10. Medtronic PLC
  • 11. Mentice AB
  • 12. Teleflex Incorporated
  • 13. Terumo Corporation
  • 14. Vasorum Ltd.
  • 15. Veryan Medical Ltd
  • 16. Vivasure Medical Ltd.

LIST OF FIGURES

  • FIGURE 1. VASCULAR INJURY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR INJURY TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR INJURY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR INJURY TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANEURYSM & PSEUDOANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIOVENOUS FISTULA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CONTUSION OR INTIMAL FLAP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY LACERATION OR TRANSECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SPASM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BYPASS GRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EXTRA ANATOMIC BYPASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY LATERAL ARTERIORRHAPHY OR VENORRHAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PATCH ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023